Glucos B. Braun

Glucos B. Braun is an intravenous solution for injection that contains glucose monohydrate as the active ingredient. It is supplied in a sterile liquid form, marketed in the European Union, and classified as a parenteral carbohydrate excipient. The product provides a readily available source of glucose for cellular metabolism during IV therapy and is used under medical supervision for fluid replacement, parenteral nutrition, and hypoglycemia management.

Glucos B. Braun is indicated for several clinical situations where an intravenous source of carbohydrate and energy is required. It is commonly employed as part of fluid therapy, parenteral nutrition regimens, and emergency treatment of low blood glucose levels.

- Fluid and electrolyte replacement in patients unable to take oral intake. - Parenteral nutrition as a carbohydrate component for patients receiving total parenteral nutrition (TPN). - Treatment of hypoglycemia when oral glucose is not feasible. - Maintenance of blood glucose levels during surgery or intensive care. - Dilution and compatibility agent for other intravenous medications.

The safety profile of Glucos B. Braun reflects the typical effects of intravenous glucose solutions.

Common: - Transient hyperglycemia, especially in patients with impaired glucose tolerance. - Local irritation at the infusion site. - Mild electrolyte shifts, such as slight changes in sodium or potassium levels. - Nausea or feeling of fullness during rapid infusion. - Headache or dizziness during infusion. - Temporary increase in blood lactate levels. - Vomiting if infusion rate is too rapid.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reactions, including rash, itching, or anaphylaxis. - Fluid overload in patients with cardiac or renal insufficiency. - Metabolic acidosis in susceptible patients.

When prescribing Glucos B. Braun, clinicians should consider several precautionary measures to ensure safe administration.

- Assess blood glucose levels before and during infusion. - Use caution in patients with diabetes mellitus or impaired glucose metabolism. - Monitor fluid balance in individuals at risk of overload, such as those with heart failure or renal disease. - Verify compatibility with other IV drugs before co‑administration. - Adjust infusion rate in neonates, infants, and pediatric patients. - Avoid rapid bolus administration unless clinically indicated. - Ensure proper storage conditions, keeping the solution at controlled temperature.

Glucos B. Braun may interact with certain medications or clinical conditions, requiring attention to avoid adverse outcomes.

Avoid: - Concurrent use with high‑dose insulin without appropriate glucose monitoring. - Simultaneous infusion of potassium chloride solutions, which can precipitate. - Co‑administration with medications that contain dextrose, leading to excess carbohydrate load.

Use with caution: - Diuretics that affect electrolyte balance, requiring close monitoring. - Beta‑blockers that may mask signs of hypoglycemia. - Corticosteroids that increase glucose production. - Cardiac glycosides in patients prone to fluid overload.